483 related articles for article (PubMed ID: 35699679)
1. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
Al-Qazazi R; Lima PDA; Prisco SZ; Potus F; Dasgupta A; Chen KH; Tian L; Bentley RET; Mewburn J; Martin AY; Wu D; Jones O; Maurice DH; Bonnet S; Provencher S; Prins KW; Archer SL
Am J Respir Crit Care Med; 2022 Sep; 206(5):608-624. PubMed ID: 35699679
[No Abstract] [Full Text] [Related]
2. Inflammatory Glycoprotein 130 Signaling Links Changes in Microtubules and Junctophilin-2 to Altered Mitochondrial Metabolism and Right Ventricular Contractility.
Prisco SZ; Hartweck LM; Rose L; Lima PDA; Thenappan T; Archer SL; Prins KW
Circ Heart Fail; 2022 Jan; 15(1):e008574. PubMed ID: 34923829
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
[TBL] [Abstract][Full Text] [Related]
4. RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis
Banerjee S; Onwunyi VRC; Hong J; Martineau S; Fishbein GA; Bonnet SB; Provencher S; Bonnet S; Umar S
bioRxiv; 2024 May; ():. PubMed ID: 38746200
[TBL] [Abstract][Full Text] [Related]
5. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane prevents right ventricular injury and reduces pulmonary vascular remodeling in pulmonary arterial hypertension.
Kang Y; Zhang G; Huang EC; Huang J; Cai J; Cai L; Wang S; Keller BB
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H853-H866. PubMed ID: 32108526
[TBL] [Abstract][Full Text] [Related]
7. Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1β (Interleukin 1β) Production.
Rong W; Liu C; Li X; Wan N; Wei L; Zhu W; Bai P; Li M; Ou Y; Li F; Wang L; Wu X; Liu J; Xing M; Zhao X; Liu H; Zhang H; Lyu A
Arterioscler Thromb Vasc Biol; 2022 May; 42(5):613-631. PubMed ID: 35387479
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
[TBL] [Abstract][Full Text] [Related]
9. Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats.
Tang B; Chen GX; Liang MY; Yao JP; Wu ZK
Int J Cardiol; 2015 Feb; 180():134-41. PubMed ID: 25438234
[TBL] [Abstract][Full Text] [Related]
10. Ketone bodies in right ventricular failure: A unique therapeutic opportunity.
Blake M; Puchalska P; Kazmirczak F; Blake J; Moon R; Thenappan T; Crawford PA; Prins KW
Heliyon; 2023 Nov; 9(11):e22227. PubMed ID: 38058654
[TBL] [Abstract][Full Text] [Related]
11. Sildenafil prevents and reverses transverse-tubule remodeling and Ca(2+) handling dysfunction in right ventricle failure induced by pulmonary artery hypertension.
Xie YP; Chen B; Sanders P; Guo A; Li Y; Zimmerman K; Wang LC; Weiss RM; Grumbach IM; Anderson ME; Song LS
Hypertension; 2012 Feb; 59(2):355-62. PubMed ID: 22203744
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
13. A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
Dai L; Chen Y; Wu J; He Z; Zhang Y; Zhang W; Xie Y; Zeng H; Zhong X
J Transl Med; 2024 Feb; 22(1):164. PubMed ID: 38365806
[TBL] [Abstract][Full Text] [Related]
14. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
[TBL] [Abstract][Full Text] [Related]
16. STING mediates SU5416/hypoxia-induced pulmonary arterial hypertension in rats by regulating macrophage NLRP3 inflammasome activation.
Wu DD; Deng Y; Liao J; Xie SS; Meng H; Lan WF
Immunobiology; 2023 Mar; 228(2):152345. PubMed ID: 36780836
[TBL] [Abstract][Full Text] [Related]
17. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
[TBL] [Abstract][Full Text] [Related]
18. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
20. Electrical Remodeling in Right Ventricular Failure Due to Pulmonary Hypertension: Unraveling Novel Therapeutic Targets.
Park JF; Liang J; Umar S
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
